OBJECTIVE: To determine the occurrence and ploidy status of usable embryos derived from oocytes not displaying two pronuclei (0PN) at the time of fertilization assessment.
DESIGN: Retrospective study in a private in vitro fertilization laboratory. MATERIALS AND METHODS: A total of 3,370 blastocysts were identified as being morphologically suitable for fresh embryo transfer, vitrification or trophectoderm biopsy for genetic testing of ploidy status followed by vitrification (i.e. usable blastocysts). Usable blastocysts were obtained on Day 5, 6, or 7. Mature oocytes were fertilized using ICSI and pronuclear assessment was performed and recorded using an inverted microscope 16-18 h post insemination. Embryos with 2 pronuclei were separated from all other embryos arising from 0PN, 1PN, 3PN and R4PN zygotes. Embryos were group cultured in a continuous single culture medium (Irvine Scientific). Chromosomal copy number was assessed for suitable blastocysts with the Illumina MiSeq platform.
RESULTS: Over the span of 18 months, 830 fresh oocyte retrievals resulted in 7,258 zygotes with two haploid pronuclei (2PN). These 2PN zygotes developed into 3,349 usable blastocysts (46%). 2.9% of the oocyte retrievals had usable blastocysts derived from oocytes not displaying pronuclei (0PN) at the time of fertilization assessment. 24 usable blastocysts (from 0PN zygotes) from 24 different patients were vitrified. 14 (58%) of these blastocysts were untested for chromosomal copy number confirmation. 10 blastocysts derived from 0PN zygotes were screened by PGS. Four embryos (44%) were reported as normal while two embryos were reported as abnormal XO and three embryos as complex abnormal XY. No transfer of a usable blastocyst derived from a 0PN has yet occurred.
CONCLUSIONS: Our results demonstrate that usable blastocysts derived from zygotes with abnormal pronuclear (0PN) formation can develop into a chromosomally normal embryo. However, these embryos may also have a high possibility of multiple chromosomal gains or losses. These results are similar to previous reports of developmental potential, chromosomal analysis and ongoing pregnancies from zygotes containing abnormal pronuclei [1] [2] [3] . Patients should be counseled regarding the chromosomal abnormalities associated with untested usable blastocysts derived from atypical zygotes. Further investigation of ploidy status of usable blastocysts derived from abnormal zygotic embryos with a single pronucleus (1PN), three pronuclei (3PN) or higher (R4PN) may provide further information regarding the retention value of abnormal pronuclear zygotes. OBJECTIVE: Improving the ex-vivo culture conditions of early embryos is still the main challenge in ART. The oxygen concentration is one of the criteria that influence protonated culture. In the uterus, early embryos are exposed to an ultra-low (1.5%) O 2 atmosphere. Moreover, embryo damage caused by reactive oxygen species (ROS) is related to the O 2 tension during in vitro culture. Currently, the traditional 6%/20% of CO 2 /O 2 or 6%/5% CO 2 / O 2 conditions are the most currently culture parameters used for early human embryo culture. However, few studies investigated the in vitro culture conditions under more physiological O 2 tension. The present study investigates the effect of ultra-low (2%) O 2 tension on blastocyst development and useful blastocyst (UB) formation rate.
DESIGN: This is a single-center observational study, performed from January 2016 to April 2017. The endpoint for the study was whether O 2 tension could enhance blastocyst development. The relationship between the oxygen tension and standard morphological evaluation according to the Gardner grading system was also examined: at day 5/6, full (grade 3), expanded (grade 4), hatching (grade 5) or fully hatched (grade 6) blastocysts with at least a grade B trophectoderm quality were considered as UBs.
MATERIALS AND METHODS: Day 1 embryos were cultured in 6% CO 2 and 5% O 2 for three days; and then in 6% CO 2 and 2% O 2 atmosphere from day 3 until day 5/6 (ultra-low O 2 group, n¼779 embryos, n¼137 patients, mean women age 33.1 years AE 4.78) or in 6% CO 2 and 5% O 2 (controls, n¼169 embryos, n¼42 patients, mean women age 33.1 years AE 4.66).
RESULTS: Blastocyst formation rate was 51 % (397/779) in the ultra-low O 2 group and 52.1% (88/169) in the control group (p¼ 0.8). The UB rate was significantly higher in the ultra-low O 2 group (282/397; 71.0%) than in the control group (40/88; 45.5%) (p<0.0001). Clinical pregnancy rate per transfer was higher but not significantly in the ultra-low O 2 group (29/89, 32.6% versus 6/23, 26.1%, p 0.76). There was no significant difference in mean patient's age between the two groups.
CONCLUSIONS: Our study demonstrates that ultra-low O 2 tension is associated with higher blastocyst quality compared to low O 2 tension, supporting the hypothesis that more physiological culture conditions improve early embryo development.
Supported by: This work was partially supported by a grant from the Ferring Pharmaceutical Company. The authors declare ni conflict of interest. OBJECTIVE: Mammalian oocytes are unique among germ cells in that they age precociously. The cellular and molecular mechanisms driving oocyte aging remain poorly understood. During meiosis in yeast, an RNA-binding protein, with a predicted prion domain, assumes an amyloid-like configuration to translationally repress cyclins and ensure homologous chromosome segregation. These findings suggest that prion domains enable formation of amyloid-like effectors in diverse settings. Since amyloid-like molecules can accelerate aging in long-lived, post mitotic cells, such as neurons, we sought to identify and characterize amyloid-like substance in oocytes, cleavage stage embryos, and blastocysts, using a murine model. DESIGN: Experimental pilot study. MATERIALS AND METHODS: Metaphase II mouse oocytes and in vivo fertilized embryos (1 cell, 2 cells, 4 cells, 8-12 cells, morulas and blastocysts) (n¼20 samples for each stage) (Embryotech Laboratories, Inc.,Wilmington, MA) were fixed and immunostained for evaluation of amyloid-like substance, using an anti-amyloid antibody (Fibrils OC Antibody [AFOC] Millipore). Imaging was performed using a confocal microscopy (Zeiss 880 laser scanning confocal microscope with a 63X Plan-Apochromat N.A. 1.4 objective). Image analysis was used to quantify immunostaining across early development.
RESULTS: In all 140 samples immunostaining for amyloid-like substance appears throughout the zona pellucida, as well as in the cytoplasm and nucleus of oocytes, polar bodies and preimplantation embryos. In oocytes, a large amount of amyloid-like substance was distributed heterogeneously throughout the cytoplasm. Less staining was identified in the polar body. In 1 and 2 cell-stage embryos, distribution within the cytoplasm was more homogeneous and more intense immunostaining was visualized in the nucleus. In 4 cell stage embryos, the amyloid-like substance was proportional between nucleus and cytoplasm. In morula stage embryos, a clear predominance of immunostaining for amyloid-like substance was observed in nuclei compared to cytoplasm. In blastocyst stage embryos, a greater concentration of amyloid-like substance appeared in inner cell mass, with nuclear staining more prominent than cytoplasmic. Trophoblast cells were devoid of amyloid-like substance. Descriptive data regarding the presence and distribution of amyloid plaques are presented.
CONCLUSIONS: We demonstrate for the first time the presence and distribution of immunostaining for an amyloid-like substance in mammalian oocytes and embryos. Since amyloid-like substances can produce cellular pathology, futures studies should investigate the role of amyloid-like substance in oocyte aging. OBJECTIVE: To study the impact of multinucleation at the 2-cell stage human embryos in vitro development, implantation and abortion rate.
DESIGN: A retrospective morphokinetical analysis of 323 Known Implantation Data (KID) embryos was performed. Analysis consisted on comparing KID and abortion relative to 2-cell stage multinucleated versus non-multinucleated embryos. We included here clinical and biochemical abortions.
MATERIALS AND METHODS: Embryos were cultured at MIRI-TLÒ incubator with Single Culture Media (IrvineÒ). Data were analysed by Student's t-test using SPSS 15.0 v. statistics software.
RESULTS: From the 323 KID embryos, 76 were multinucleated at the two cell stage (23,5%). Among them, 26 were KID+ and 50 KID-(34,2% vs. 65,6% respectively). The other 247 embryos (76,5%), showed no multinucleation; 61 were KID+ (24,7%) and 186 were KID-(75,3%). No significant differences were found between implantation status (KID+/KID-) of multinucleated and non-multinucleated embryos. Regarding abortion, no
